The Latest Furor Over Trump’s Drug Pricing Plan

Did the head of the Office and Management & Budget really endorse Part D rebates? Like so much about the Trump Administration’s response to drug pricing, there is probably a lot less to the story than it sounds.

Silhouette-Seniors-In-Pills_1200x675

More from Pricing Debate

More from Market Access